HIF1A and osteoporosis: With genetic editing or pharmacological methods used to change HIF1α expression, multiple pathological bone metabolism diseases are attenuated, including oral periapical lesions, osteoporosis caused by estrogen or androgen deficiency, pathologic bone fractures and cranial defects [1, 24–28].